Menu

SBV in the Press: Puducherry institution chosen for human clinical trials of Covaxin

MGMCRI is selected as one of the few notable centers in our country for conducting Phase III Multi-centric Clinical Trial of COVAXIN. This remarkable achievement got a special mention in newspapers. At MGMCRI, the trials will begin soon; 1,200 volunteers likely to be covered. To know further please click on the link given below and also check the attachment for details.

http://www.uniindia.com/mgmcri-selected-for-phase-iii-clinical-trials-of-covaxin/south/news/2243921.html

https://www.thehindu.com/news/cities/puducherry/puducherry-institution-chosen-for-human-clinical-trials-of-covaxin/article33207948.ece

X